- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVAX
Recent news which mentions NVAX
From MarketWatch
Why the S&P 500 may sink as low as 3,100 next year, warn these bearish strategists
November 28, 2023
From MarketWatch
Could a Short Squeeze Be Coming for These 3 Heavily Shorted Stocks?
November 15, 2023
From Motley Fool
Where Will Novavax Be in 3 Years?
November 11, 2023
From Motley Fool
Novavax Prepares Further Cost Cuts To Better Align With Demand-Challenged COVID-19 Vaccine Market
November 09, 2023
Tickers
NVAX
From Benzinga
Novavax shares rise as third quarter results top expectations
November 09, 2023
From MarketWatch
Wall Street To Snap Longest Winning Streak Since 2021 Today? Earnings, Bond Yields In Focus Ahead Of Powell's Speech
November 09, 2023
From Benzinga
S&P 500 futures struggle to extend eight-day winning streak ahead of Powell comments
November 09, 2023
From MarketWatch
Down 75% From Its High, Has Novavax Stock Become Too Cheap to Pass Up?
November 02, 2023
Tickers
NVAX
From Motley Fool
7 Dangerous Stocks to Avoid No Matter What
November 01, 2023
From InvestorPlace
WeWork shares plunge on report of looming bankruptcy as Match Group stock slumps on Tinder owner’s Israel warning
November 01, 2023
From MarketWatch
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
October 18, 2023
From Benzinga
Do These 5 Words From Pfizer Mean Trouble for Novavax?
October 17, 2023
From Motley Fool
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 16, 2023
From Benzinga
Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories
October 16, 2023
From Benzinga
Moderna confirms COVID sales guidance as shares sink on Pfizer news
October 16, 2023
From MarketWatch
Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine
October 16, 2023
From Benzinga
US Stocks On Track For A Strong Start To Week, Buoyed By Earnings Optimism: Analyst Flags 13-14% Upside As Bull Market Enters Its Second Year
October 16, 2023
From Benzinga
From Benzinga
Is Novavax Stock a Buy Now?
October 16, 2023
From Motley Fool
Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the move
October 16, 2023
From MarketWatch
Pfizer’s stock sinks after company cuts outlook on lower demand for COVID treatments
October 13, 2023
From MarketWatch
Novavax (NVAX) Stock Slides Despite Vaccine Availability
October 13, 2023
From InvestorPlace
The Fall Vaccination Season Is Here. Is Novavax a Buy?
October 12, 2023
Tickers
NVAX
From Motley Fool
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 11, 2023
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.